FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
An FDA advisory committee has unanimously backed Moderna's mRNA-based flu vaccine, marking a significant development for the technology.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
An FDA advisory committee has provided unanimous support for a first-of-its-kind influenza vaccine developed by Moderna. The panel's review process centered on the efficacy and viability of applying mRNA technology to flu prevention.
Coverage from Fierce Biotech, Bloomberg, and AP News confirms the unanimous nature of the committee votes. Reports from Yahoo Finance note that the review process has influenced market activity for Moderna (MRNA) stock.
Coverage does not yet specify a final timeline for formal FDA approval or distribution. Observers are now looking for the agency's official response to the committee's recommendation.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 44d ago.
Quick answers
What technology does the new flu vaccine use?
The vaccine utilizes mRNA technology.
What was the outcome of the FDA advisory committee vote?
The committee voted unanimously to back the candidate.
Has the FDA officially approved the vaccine?
Coverage does not yet specify a final approval decision from the FDA.
Coverage (10)
- Moderna just got a signal investors can’t ignore Yahoo Finance · 44d ago
- FDA panel backs first-of-its-kind flu vaccine using mRNA technology Los Angeles Times · 44d ago
- FDA panel supports first mRNA-based flu vaccine KOMO · 44d ago
- Moderna flu vaccine wins unanimous support from FDA panel BioPharma Dive · 44d ago
- New First-of-Its-Kind Flu Vaccine Approved by FDA Expert Panel ScienceAlert · 44d ago
- Moderna’s flu candidate sails through FDA advisory committee in unanimous votes Fierce Biotech · 45d ago
- Moderna Extends Rally as FDA Advisory Panel Reviews Flu Vaccine Application (MRNA) Yahoo Finance · 45d ago
- Moderna’s mRNA Flu Vaccine Wins FDA Advisory Committee Backing Bloomberg.com · 45d ago
- FDA vaccine panel set to review Moderna mRNA flu shot The Hill · 45d ago
- FDA panel considers a first-of-its-kind flu vaccine using mRNA technology AP News · 45d ago
Topics
Related trends
FDA Panel Backs 6 Peptides for Compounding
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Nearly 12 million bottles of Rohto eye drops over sterility concerns, FDA announces
The FDA announces a recall of nearly 12 million bottles of Rohto eye drops due to sterility concerns.
Fruit sold at Publix sickens multiple people in 8 states
12 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Replimune’s twice-rejected melanoma drug prevails in FDA adcomm
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
New, more efficient pill to lower cholesterol
FDA approves first oral PCSK9 inhibitor for adults with high cholesterol, changing treatment options.
FDA Panel Votes In Favor of Replimune’s Melanoma Treatment
Replimune shares surge following a favorable FDA advisory panel vote for its melanoma treatment.